DaVita Net Profit Margin 2010-2024 | DVA

Current and historical net profit margin for DaVita (DVA) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. DaVita net profit margin for the three months ending September 30, 2024 was .
DaVita Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $12.67B $0.83B 6.54%
2024-06-30 $12.53B $0.86B 6.87%
2024-03-31 $12.34B $0.82B 6.62%
2023-12-31 $12.14B $0.69B 5.71%
2023-09-30 $11.91B $0.61B 5.12%
2023-06-30 $11.74B $0.47B 3.99%
2023-03-31 $11.67B $0.51B 4.41%
2022-12-31 $11.61B $0.56B 4.82%
2022-09-30 $11.64B $0.68B 5.83%
2022-06-30 $11.63B $0.83B 7.17%
2022-03-31 $11.62B $0.90B 7.77%
2021-12-31 $11.62B $0.98B 8.42%
2021-09-30 $11.58B $0.97B 8.33%
2021-06-30 $11.57B $0.86B 7.47%
2021-03-31 $11.53B $0.77B 6.70%
2020-12-31 $11.55B $0.78B 6.71%
2020-09-30 $11.54B $0.85B 7.33%
2020-06-30 $11.52B $0.83B 7.20%
2020-03-31 $11.49B $0.90B 7.85%
2019-12-31 $11.39B $0.81B 7.12%
2019-09-30 $11.31B $0.42B 3.68%
2019-06-30 $11.25B $0.14B 1.21%
2019-03-31 $11.30B $0.13B 1.14%
2018-12-31 $11.40B $0.16B 1.39%
2018-09-30 $11.36B $0.61B 5.39%
2018-06-30 $11.28B $0.54B 4.74%
2018-03-31 $11.09B $0.40B 3.56%
2017-12-31 $10.88B $0.66B 6.11%
2017-09-30 $7.77B $0.52B 6.68%
2017-06-30 $8.74B $1.30B 14.92%
2017-03-31 $9.76B $1.23B 12.61%
2016-12-31 $10.71B $0.88B 8.21%
2016-09-30 $10.76B $0.72B 6.64%
2016-06-30 $10.56B $0.36B 3.41%
2016-03-31 $10.28B $0.48B 4.64%
2015-12-31 $9.98B $0.27B 2.69%
2015-09-30 $13.58B $0.48B 3.56%
2015-06-30 $13.30B $0.45B 3.39%
2015-03-31 $13.04B $0.43B 3.29%
2014-12-31 $12.80B $0.72B 5.65%
2014-09-30 $12.53B $0.73B 5.80%
2014-06-30 $12.28B $0.68B 5.54%
2014-03-31 $11.98B $0.79B 6.56%
2013-12-31 $11.77B $0.63B 5.38%
2013-09-30 $11.18B $0.58B 5.16%
2013-06-30 $10.13B $0.59B 5.78%
2013-03-31 $9.17B $0.43B 4.65%
2012-12-31 $8.19B $0.54B 6.55%
2012-09-30 $7.46B $0.53B 7.08%
2012-06-30 $7.27B $0.52B 7.12%
2012-03-31 $7.02B $0.52B 7.45%
2011-12-31 $6.73B $0.48B 7.10%
2011-09-30 $6.41B $0.40B 6.23%
2011-06-30 $6.30B $0.38B 6.08%
2011-03-31 $6.22B $0.39B 6.28%
2010-12-31 $6.22B $0.41B 6.51%
2010-09-30 $6.36B $0.45B 7.02%
2010-06-30 $6.28B $0.44B 6.97%
2010-03-31 $6.21B $0.44B 7.02%
2009-12-31 $6.10B $0.42B 6.93%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.872B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00